img

Global Genetic Disease Diagnostic Market Research Report 2024

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Genetic Disease Diagnostic Market Research Report 2024

Hereditary diseases are those caused by changes in genetic material or controlled by disease-causing genes. Hereditary diseases refer to diseases that are determined wholly or partly by genetic factors, usually congenital or acquired. Be like congenital foolish model, much point to (toe), congenital deafness dumb, hemophilia, these hereditary disease decides to come on completely by genetic factor, and just after be born certain time comes on, want to pass a few years sometimes, more than ten years even ability after decades appears apparent symptom.At present, China has adopted a variety of neonatal disease screening technologies for early diagnosis and treatment of children with genetic diseases without clinical symptoms, effectively reducing the disability rate and mortality rate of children, and greatly reducing the serious harm caused by birth defects to families and society. In recent years, with the rapid development of molecular biology and genomics, genetic testing technology has become the gold standard when it comes to most of the hereditary disease diagnosis, especially in the biochemical or enzymatic method can't make a diagnosis and test results under the condition of not clear, genetic testing is an important means of diagnosis, but in the field of neonatal hereditary disease screening, genetic testing technology is not yet ripe for applications, Gene screening for neonatal deafness has been reported in China.
According to MRAResearch’s new survey, global Genetic Disease Diagnostic market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Genetic Disease Diagnostic market research.
In China markets, the core manufacturers of genetic disease diagnostic includes BGI Group, Berry Genomics etc and the top 5 companies hold a share over 40%.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Genetic Disease Diagnostic market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Abbott
PerkinElmer
Roche Diagnostics
Bio Rad
Thermo Fisher Scientific
BGI Group
Berry Genomics
Da An Gene Co., Ltd.
Illumina
CapitalBio Technology
Segment by Type
Prenatal Diagnosis
Screening for Single Gene Genetic Disease
Preimplantation Genetic Testing
Others

Segment by Application


Hospital
Medical Laboratory
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Genetic Disease Diagnostic report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Genetic Disease Diagnostic Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Prenatal Diagnosis
1.2.3 Screening for Single Gene Genetic Disease
1.2.4 Preimplantation Genetic Testing
1.2.5 Others
1.3 Market by Application
1.3.1 Global Genetic Disease Diagnostic Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospital
1.3.3 Medical Laboratory
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Genetic Disease Diagnostic Market Perspective (2018-2033)
2.2 Genetic Disease Diagnostic Growth Trends by Region
2.2.1 Global Genetic Disease Diagnostic Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Genetic Disease Diagnostic Historic Market Size by Region (2018-2023)
2.2.3 Genetic Disease Diagnostic Forecasted Market Size by Region (2024-2033)
2.3 Genetic Disease Diagnostic Market Dynamics
2.3.1 Genetic Disease Diagnostic Industry Trends
2.3.2 Genetic Disease Diagnostic Market Drivers
2.3.3 Genetic Disease Diagnostic Market Challenges
2.3.4 Genetic Disease Diagnostic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Genetic Disease Diagnostic Players by Revenue
3.1.1 Global Top Genetic Disease Diagnostic Players by Revenue (2018-2023)
3.1.2 Global Genetic Disease Diagnostic Revenue Market Share by Players (2018-2023)
3.2 Global Genetic Disease Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Genetic Disease Diagnostic Revenue
3.4 Global Genetic Disease Diagnostic Market Concentration Ratio
3.4.1 Global Genetic Disease Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Genetic Disease Diagnostic Revenue in 2022
3.5 Genetic Disease Diagnostic Key Players Head office and Area Served
3.6 Key Players Genetic Disease Diagnostic Product Solution and Service
3.7 Date of Enter into Genetic Disease Diagnostic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Genetic Disease Diagnostic Breakdown Data by Type
4.1 Global Genetic Disease Diagnostic Historic Market Size by Type (2018-2023)
4.2 Global Genetic Disease Diagnostic Forecasted Market Size by Type (2024-2033)
5 Genetic Disease Diagnostic Breakdown Data by Application
5.1 Global Genetic Disease Diagnostic Historic Market Size by Application (2018-2023)
5.2 Global Genetic Disease Diagnostic Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Genetic Disease Diagnostic Market Size (2018-2033)
6.2 North America Genetic Disease Diagnostic Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Genetic Disease Diagnostic Market Size by Country (2018-2023)
6.4 North America Genetic Disease Diagnostic Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Genetic Disease Diagnostic Market Size (2018-2033)
7.2 Europe Genetic Disease Diagnostic Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Genetic Disease Diagnostic Market Size by Country (2018-2023)
7.4 Europe Genetic Disease Diagnostic Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Genetic Disease Diagnostic Market Size (2018-2033)
8.2 Asia-Pacific Genetic Disease Diagnostic Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Genetic Disease Diagnostic Market Size by Region (2018-2023)
8.4 Asia-Pacific Genetic Disease Diagnostic Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Genetic Disease Diagnostic Market Size (2018-2033)
9.2 Latin America Genetic Disease Diagnostic Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Genetic Disease Diagnostic Market Size by Country (2018-2023)
9.4 Latin America Genetic Disease Diagnostic Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Genetic Disease Diagnostic Market Size (2018-2033)
10.2 Middle East & Africa Genetic Disease Diagnostic Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Genetic Disease Diagnostic Market Size by Country (2018-2023)
10.4 Middle East & Africa Genetic Disease Diagnostic Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Detail
11.1.2 Abbott Business Overview
11.1.3 Abbott Genetic Disease Diagnostic Introduction
11.1.4 Abbott Revenue in Genetic Disease Diagnostic Business (2018-2023)
11.1.5 Abbott Recent Development
11.2 PerkinElmer
11.2.1 PerkinElmer Company Detail
11.2.2 PerkinElmer Business Overview
11.2.3 PerkinElmer Genetic Disease Diagnostic Introduction
11.2.4 PerkinElmer Revenue in Genetic Disease Diagnostic Business (2018-2023)
11.2.5 PerkinElmer Recent Development
11.3 Roche Diagnostics
11.3.1 Roche Diagnostics Company Detail
11.3.2 Roche Diagnostics Business Overview
11.3.3 Roche Diagnostics Genetic Disease Diagnostic Introduction
11.3.4 Roche Diagnostics Revenue in Genetic Disease Diagnostic Business (2018-2023)
11.3.5 Roche Diagnostics Recent Development
11.4 Bio Rad
11.4.1 Bio Rad Company Detail
11.4.2 Bio Rad Business Overview
11.4.3 Bio Rad Genetic Disease Diagnostic Introduction
11.4.4 Bio Rad Revenue in Genetic Disease Diagnostic Business (2018-2023)
11.4.5 Bio Rad Recent Development
11.5 Thermo Fisher Scientific
11.5.1 Thermo Fisher Scientific Company Detail
11.5.2 Thermo Fisher Scientific Business Overview
11.5.3 Thermo Fisher Scientific Genetic Disease Diagnostic Introduction
11.5.4 Thermo Fisher Scientific Revenue in Genetic Disease Diagnostic Business (2018-2023)
11.5.5 Thermo Fisher Scientific Recent Development
11.6 BGI Group
11.6.1 BGI Group Company Detail
11.6.2 BGI Group Business Overview
11.6.3 BGI Group Genetic Disease Diagnostic Introduction
11.6.4 BGI Group Revenue in Genetic Disease Diagnostic Business (2018-2023)
11.6.5 BGI Group Recent Development
11.7 Berry Genomics
11.7.1 Berry Genomics Company Detail
11.7.2 Berry Genomics Business Overview
11.7.3 Berry Genomics Genetic Disease Diagnostic Introduction
11.7.4 Berry Genomics Revenue in Genetic Disease Diagnostic Business (2018-2023)
11.7.5 Berry Genomics Recent Development
11.8 Da An Gene Co., Ltd.
11.8.1 Da An Gene Co., Ltd. Company Detail
11.8.2 Da An Gene Co., Ltd. Business Overview
11.8.3 Da An Gene Co., Ltd. Genetic Disease Diagnostic Introduction
11.8.4 Da An Gene Co., Ltd. Revenue in Genetic Disease Diagnostic Business (2018-2023)
11.8.5 Da An Gene Co., Ltd. Recent Development
11.9 Illumina
11.9.1 Illumina Company Detail
11.9.2 Illumina Business Overview
11.9.3 Illumina Genetic Disease Diagnostic Introduction
11.9.4 Illumina Revenue in Genetic Disease Diagnostic Business (2018-2023)
11.9.5 Illumina Recent Development
11.10 CapitalBio Technology
11.10.1 CapitalBio Technology Company Detail
11.10.2 CapitalBio Technology Business Overview
11.10.3 CapitalBio Technology Genetic Disease Diagnostic Introduction
11.10.4 CapitalBio Technology Revenue in Genetic Disease Diagnostic Business (2018-2023)
11.10.5 CapitalBio Technology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Genetic Disease Diagnostic Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Prenatal Diagnosis
Table 3. Key Players of Screening for Single Gene Genetic Disease
Table 4. Key Players of Preimplantation Genetic Testing
Table 5. Key Players of Others
Table 6. Global Genetic Disease Diagnostic Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Genetic Disease Diagnostic Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Genetic Disease Diagnostic Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Genetic Disease Diagnostic Market Share by Region (2018-2023)
Table 10. Global Genetic Disease Diagnostic Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 11. Global Genetic Disease Diagnostic Market Share by Region (2024-2033)
Table 12. Genetic Disease Diagnostic Market Trends
Table 13. Genetic Disease Diagnostic Market Drivers
Table 14. Genetic Disease Diagnostic Market Challenges
Table 15. Genetic Disease Diagnostic Market Restraints
Table 16. Global Genetic Disease Diagnostic Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Genetic Disease Diagnostic Market Share by Players (2018-2023)
Table 18. Global Top Genetic Disease Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genetic Disease Diagnostic as of 2022)
Table 19. Ranking of Global Top Genetic Disease Diagnostic Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Genetic Disease Diagnostic Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Genetic Disease Diagnostic Product Solution and Service
Table 23. Date of Enter into Genetic Disease Diagnostic Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Genetic Disease Diagnostic Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Genetic Disease Diagnostic Revenue Market Share by Type (2018-2023)
Table 27. Global Genetic Disease Diagnostic Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 28. Global Genetic Disease Diagnostic Revenue Market Share by Type (2024-2033)
Table 29. Global Genetic Disease Diagnostic Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Genetic Disease Diagnostic Revenue Market Share by Application (2018-2023)
Table 31. Global Genetic Disease Diagnostic Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 32. Global Genetic Disease Diagnostic Revenue Market Share by Application (2024-2033)
Table 33. North America Genetic Disease Diagnostic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 34. North America Genetic Disease Diagnostic Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Genetic Disease Diagnostic Market Size by Country (2024-2033) & (US$ Million)
Table 36. Europe Genetic Disease Diagnostic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. Europe Genetic Disease Diagnostic Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Genetic Disease Diagnostic Market Size by Country (2024-2033) & (US$ Million)
Table 39. Asia-Pacific Genetic Disease Diagnostic Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 40. Asia-Pacific Genetic Disease Diagnostic Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Genetic Disease Diagnostic Market Size by Region (2024-2033) & (US$ Million)
Table 42. Latin America Genetic Disease Diagnostic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Latin America Genetic Disease Diagnostic Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Genetic Disease Diagnostic Market Size by Country (2024-2033) & (US$ Million)
Table 45. Middle East & Africa Genetic Disease Diagnostic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 46. Middle East & Africa Genetic Disease Diagnostic Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Genetic Disease Diagnostic Market Size by Country (2024-2033) & (US$ Million)
Table 48. Abbott Company Detail
Table 49. Abbott Business Overview
Table 50. Abbott Genetic Disease Diagnostic Product
Table 51. Abbott Revenue in Genetic Disease Diagnostic Business (2018-2023) & (US$ Million)
Table 52. Abbott Recent Development
Table 53. PerkinElmer Company Detail
Table 54. PerkinElmer Business Overview
Table 55. PerkinElmer Genetic Disease Diagnostic Product
Table 56. PerkinElmer Revenue in Genetic Disease Diagnostic Business (2018-2023) & (US$ Million)
Table 57. PerkinElmer Recent Development
Table 58. Roche Diagnostics Company Detail
Table 59. Roche Diagnostics Business Overview
Table 60. Roche Diagnostics Genetic Disease Diagnostic Product
Table 61. Roche Diagnostics Revenue in Genetic Disease Diagnostic Business (2018-2023) & (US$ Million)
Table 62. Roche Diagnostics Recent Development
Table 63. Bio Rad Company Detail
Table 64. Bio Rad Business Overview
Table 65. Bio Rad Genetic Disease Diagnostic Product
Table 66. Bio Rad Revenue in Genetic Disease Diagnostic Business (2018-2023) & (US$ Million)
Table 67. Bio Rad Recent Development
Table 68. Thermo Fisher Scientific Company Detail
Table 69. Thermo Fisher Scientific Business Overview
Table 70. Thermo Fisher Scientific Genetic Disease Diagnostic Product
Table 71. Thermo Fisher Scientific Revenue in Genetic Disease Diagnostic Business (2018-2023) & (US$ Million)
Table 72. Thermo Fisher Scientific Recent Development
Table 73. BGI Group Company Detail
Table 74. BGI Group Business Overview
Table 75. BGI Group Genetic Disease Diagnostic Product
Table 76. BGI Group Revenue in Genetic Disease Diagnostic Business (2018-2023) & (US$ Million)
Table 77. BGI Group Recent Development
Table 78. Berry Genomics Company Detail
Table 79. Berry Genomics Business Overview
Table 80. Berry Genomics Genetic Disease Diagnostic Product
Table 81. Berry Genomics Revenue in Genetic Disease Diagnostic Business (2018-2023) & (US$ Million)
Table 82. Berry Genomics Recent Development
Table 83. Da An Gene Co., Ltd. Company Detail
Table 84. Da An Gene Co., Ltd. Business Overview
Table 85. Da An Gene Co., Ltd. Genetic Disease Diagnostic Product
Table 86. Da An Gene Co., Ltd. Revenue in Genetic Disease Diagnostic Business (2018-2023) & (US$ Million)
Table 87. Da An Gene Co., Ltd. Recent Development
Table 88. Illumina Company Detail
Table 89. Illumina Business Overview
Table 90. Illumina Genetic Disease Diagnostic Product
Table 91. Illumina Revenue in Genetic Disease Diagnostic Business (2018-2023) & (US$ Million)
Table 92. Illumina Recent Development
Table 93. CapitalBio Technology Company Detail
Table 94. CapitalBio Technology Business Overview
Table 95. CapitalBio Technology Genetic Disease Diagnostic Product
Table 96. CapitalBio Technology Revenue in Genetic Disease Diagnostic Business (2018-2023) & (US$ Million)
Table 97. CapitalBio Technology Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Genetic Disease Diagnostic Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Genetic Disease Diagnostic Market Share by Type: 2022 VS 2033
Figure 3. Prenatal Diagnosis Features
Figure 4. Screening for Single Gene Genetic Disease Features
Figure 5. Preimplantation Genetic Testing Features
Figure 6. Others Features
Figure 7. Global Genetic Disease Diagnostic Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 8. Global Genetic Disease Diagnostic Market Share by Application: 2022 VS 2033
Figure 9. Hospital Case Studies
Figure 10. Medical Laboratory Case Studies
Figure 11. Others Case Studies
Figure 12. Genetic Disease Diagnostic Report Years Considered
Figure 13. Global Genetic Disease Diagnostic Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 14. Global Genetic Disease Diagnostic Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 15. Global Genetic Disease Diagnostic Market Share by Region: 2022 VS 2033
Figure 16. Global Genetic Disease Diagnostic Market Share by Players in 2022
Figure 17. Global Top Genetic Disease Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genetic Disease Diagnostic as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Genetic Disease Diagnostic Revenue in 2022
Figure 19. North America Genetic Disease Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. North America Genetic Disease Diagnostic Market Share by Country (2018-2033)
Figure 21. United States Genetic Disease Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Canada Genetic Disease Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Genetic Disease Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Genetic Disease Diagnostic Market Share by Country (2018-2033)
Figure 25. Germany Genetic Disease Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. France Genetic Disease Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. U.K. Genetic Disease Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Italy Genetic Disease Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Russia Genetic Disease Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Nordic Countries Genetic Disease Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Genetic Disease Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific Genetic Disease Diagnostic Market Share by Region (2018-2033)
Figure 33. China Genetic Disease Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Japan Genetic Disease Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. South Korea Genetic Disease Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Southeast Asia Genetic Disease Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. India Genetic Disease Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Australia Genetic Disease Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Genetic Disease Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America Genetic Disease Diagnostic Market Share by Country (2018-2033)
Figure 41. Mexico Genetic Disease Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Brazil Genetic Disease Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Genetic Disease Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa Genetic Disease Diagnostic Market Share by Country (2018-2033)
Figure 45. Turkey Genetic Disease Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Saudi Arabia Genetic Disease Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Abbott Revenue Growth Rate in Genetic Disease Diagnostic Business (2018-2023)
Figure 48. PerkinElmer Revenue Growth Rate in Genetic Disease Diagnostic Business (2018-2023)
Figure 49. Roche Diagnostics Revenue Growth Rate in Genetic Disease Diagnostic Business (2018-2023)
Figure 50. Bio Rad Revenue Growth Rate in Genetic Disease Diagnostic Business (2018-2023)
Figure 51. Thermo Fisher Scientific Revenue Growth Rate in Genetic Disease Diagnostic Business (2018-2023)
Figure 52. BGI Group Revenue Growth Rate in Genetic Disease Diagnostic Business (2018-2023)
Figure 53. Berry Genomics Revenue Growth Rate in Genetic Disease Diagnostic Business (2018-2023)
Figure 54. Da An Gene Co., Ltd. Revenue Growth Rate in Genetic Disease Diagnostic Business (2018-2023)
Figure 55. Illumina Revenue Growth Rate in Genetic Disease Diagnostic Business (2018-2023)
Figure 56. CapitalBio Technology Revenue Growth Rate in Genetic Disease Diagnostic Business (2018-2023)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries